(R)-[2-(tert-butyl-dimethyl-silanyloxy)-1-methyl-ethylamino]-acetic acid tert-butyl ester | 905815-73-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (R)-[2-(tert-butyl-dimethyl-silanyloxy)-1-methyl-ethylamino]-acetic acid tert-butyl ester
• 英文别名: tert-butyl 2-[[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]amino]acetate
• CAS: 905815-73-8
• 化学式: C₁₅H₃₃NO₃Si
• 分子量: 303.517
• InChiKey: JYGPCYNPPSXPGE-GFCCVEGCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.33
• 重原子数：
  20
• 可旋转键数：
  9
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.93
• 拓扑面积：
  47.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (R)-[2-(tert-butyl-dimethyl-silanyloxy)-1-methyl-ethylamino]-acetic acid tert-butyl ester 在 盐酸 、 PS-PPh3 、 溶剂黄146 、 triethylamine tris(hydrogen fluoride) 、 N,N-二异丙基乙胺 、 偶氮二甲酸二乙酯 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 19.0h， 生成 ({(R)-2-[2-(3-Fluoro-phenylsulfanyl)-phenoxy]-1-methyl-ethyl}-methyl-amino)-acetic acid
  参考文献：
  名称：

  The synthesis and SAR of 2-arylsulfanylphenyl-1-oxyalkylamino acids as GlyT-1 inhibitors

  摘要：

  Elevation of glycine levels by inhibition of the glycine transporter-1 (GlyT-1) and activation of the NMDA receptor is a potential strategy for the treatment of schizophrenia. A novel series of 2-arylsulfanylphenyl-1-oxyalkyl amino acids have been identified. The most prominent member of this series S-1-{2-[3-(3-fluoro-phenylsulfanyl)biphenyl-4-yloxy]ethyl} pyrrolidine-2-carboxylic acid (38) is a potent GlyT-1 inhibitor (IC50 = 59 nM). In vitro and in vivo assessment of CNS exposure indicates this compound is a likely substrate for active efflux transporters. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.05.017
• 作为产物：
  描述：

  (R)-1-((tert-butyldimethylsilyl)oxy)propan-2-amine 、 溴乙酸叔丁酯 在 N,N-二异丙基乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 16.0h， 生成 (R)-[2-(tert-butyl-dimethyl-silanyloxy)-1-methyl-ethylamino]-acetic acid tert-butyl ester
  参考文献：
  名称：

  The synthesis and SAR of 2-arylsulfanylphenyl-1-oxyalkylamino acids as GlyT-1 inhibitors

  摘要：

  Elevation of glycine levels by inhibition of the glycine transporter-1 (GlyT-1) and activation of the NMDA receptor is a potential strategy for the treatment of schizophrenia. A novel series of 2-arylsulfanylphenyl-1-oxyalkyl amino acids have been identified. The most prominent member of this series S-1-{2-[3-(3-fluoro-phenylsulfanyl)biphenyl-4-yloxy]ethyl} pyrrolidine-2-carboxylic acid (38) is a potent GlyT-1 inhibitor (IC50 = 59 nM). In vitro and in vivo assessment of CNS exposure indicates this compound is a likely substrate for active efflux transporters. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.05.017

文献信息

• The synthesis and SAR of 2-arylsulfanylphenyl-1-oxyalkylamino acids as GlyT-1 inhibitors
  作者：Garrick Smith、Gitte Mikkelsen、Jørgen Eskildsen、Christoffer Bundgaard

  DOI：10.1016/j.bmcl.2006.05.017

  日期：2006.8

  Elevation of glycine levels by inhibition of the glycine transporter-1 (GlyT-1) and activation of the NMDA receptor is a potential strategy for the treatment of schizophrenia. A novel series of 2-arylsulfanylphenyl-1-oxyalkyl amino acids have been identified. The most prominent member of this series S-1-2-[3-(3-fluoro-phenylsulfanyl)biphenyl-4-yloxy]ethyl} pyrrolidine-2-carboxylic acid (38) is a potent GlyT-1 inhibitor (IC50 = 59 nM). In vitro and in vivo assessment of CNS exposure indicates this compound is a likely substrate for active efflux transporters. (c) 2006 Elsevier Ltd. All rights reserved.